Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does host complement kill Borrelia burgdorferi within ticks?

Sivaprakash Rathinavelu1, Anne Broadwater, Aravinda M de Silva

  • 1Department of Microbiology and Immunology, University of North Carolina, Chapel Hill 27599, USA.

Infection and Immunity
|January 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of a tetravalent live dengue virus vaccine in children responding to one serotype only.

JCI insight·2026
Same author

A Novel Adaptive Platform for Rapid, Simple Flow-Based Antibody Detection Devices Predicts NAb Levels to SARS-CoV-2.

Pathogens & immunity·2026
Same author

An ultrapotent human antibody neutralizes all maturation states of Zika virus.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

CD4<sup>+</sup> T Cells Are Key to Shaping a Protective Humoral Immunity in Primary Dengue 2 Virus Infection: Implications for Rational Vaccine Design.

Vaccines·2025
Same author

Acute Febrile Illness Associated with an Emerging Dengue 4 GIIb Variant Causing Epidemic in León, Nicaragua 2022.

Viruses·2025
Same author

Protective envelope dimer epitope-like antibodies are elicited against dengue virus in children after infection and vaccination.

Science translational medicine·2025
Same journal

<i>Porphyromonas gingivalis</i> sphingolipids affect early responses of THP-1 macrophages to outer membrane vesicles.

Infection and immunity·2026
Same journal

A genome-wide CRISPR screen defines host determinants of early <i>Brucella</i> infection in human macrophage-like cells.

Infection and immunity·2026
Same journal

Antiphospholipid antibodies in acute and post-treatment Lyme disease.

Infection and immunity·2026
Same journal

The cholesterol-dependent cytolysin promotes <i>Streptococcus</i> systemic spread and induces arachidonic acid accumulation-mediated lethality in a murine intraperitoneal infection model.

Infection and immunity·2026
Same journal

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same journal

<i>Staphylococcus aureus</i> pore-forming toxins differentially shape disease severity in experimental endophthalmitis.

Infection and immunity·2026
See all related articles

Host complement does not kill Lyme disease bacteria in ticks because it is inactivated. However, OspA antibodies block transmission, with complement enhancing larval acquisition but not nymphal transmission.

Area of Science:

  • Immunology
  • Microbiology
  • Vector-borne diseases

Background:

  • Borrelia burgdorferi, the Lyme disease spirochete, resides in the tick vector's gut.
  • Host blood exposure occurs during tick feeding, potentially activating the complement system.

Purpose of the Study:

  • To investigate the role of the host complement system in eliminating spirochetes within the tick vector.
  • To determine if complement is required for the efficacy of the OspA vaccine in blocking Lyme disease transmission.

Main Methods:

  • Studies utilized normal and complement-deficient (C3-knockout) mice.
  • Experiments involved hyperimmunization with Outer Surface Protein A (OspA) vaccine in mice.
  • Spirochete numbers in feeding nymphs and transmission to hosts were assessed.

Related Experiment Videos

Main Results:

  • Complement did not affect spirochete numbers in feeding nymphs, likely due to complement inactivation within the vector.
  • OspA-vaccinated mice showed complement-independent killing of spirochetes and blocked transmission from nymphs.
  • Host complement enhanced OspA antibody's ability to prevent spirochete acquisition by larvae.

Conclusions:

  • Complement inactivation within the tick vector limits its role in controlling Borrelia burgdorferi.
  • The OspA vaccine effectively blocks Lyme disease transmission independently of complement for nymphal stages.
  • Distinct mechanisms involving complement influence OspA antibody's efficacy in preventing larval acquisition versus nymphal transmission.